DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,319,000 | +1.9% | 19,188 | +0.6% | 0.20% | -6.4% |
| Q4 2020 | $4,239,000 | +12.9% | 19,081 | +1.7% | 0.22% | +1.9% |
| Q3 2020 | $3,753,000 | +12.8% | 18,766 | -0.3% | 0.22% | +8.0% |
| Q2 2020 | $3,327,000 | +34.3% | 18,818 | +5.1% | 0.20% | +12.4% |
| Q1 2020 | $2,477,000 | -10.9% | 17,899 | -1.2% | 0.18% | +12.0% |
| Q4 2019 | $2,780,000 | -8.8% | 18,113 | -14.2% | 0.16% | -19.8% |
| Q3 2019 | $3,049,000 | +1.0% | 21,107 | -0.0% | 0.20% | +8.2% |
| Q2 2019 | $3,018,000 | +9.1% | 21,115 | +0.8% | 0.18% | +4.6% |
| Q1 2019 | $2,766,000 | +30.5% | 20,953 | +1.9% | 0.17% | +14.5% |
| Q4 2018 | $2,120,000 | +3.9% | 20,556 | +9.5% | 0.15% | +25.6% |
| Q3 2018 | $2,040,000 | +9.7% | 18,776 | -0.4% | 0.12% | +2.5% |
| Q2 2018 | $1,860,000 | +14.9% | 18,849 | +13.9% | 0.12% | +13.5% |
| Q1 2018 | $1,619,000 | +26.6% | 16,543 | +20.0% | 0.10% | +28.4% |
| Q4 2017 | $1,279,000 | +7.6% | 13,781 | -0.6% | 0.08% | +3.8% |
| Q3 2017 | $1,189,000 | -4.3% | 13,860 | -5.9% | 0.08% | -4.9% |
| Q2 2017 | $1,243,000 | -8.5% | 14,735 | -7.2% | 0.08% | -9.9% |
| Q1 2017 | $1,358,000 | +7.1% | 15,879 | -2.5% | 0.09% | +2.2% |
| Q4 2016 | $1,268,000 | -5.9% | 16,283 | -5.4% | 0.09% | -8.2% |
| Q3 2016 | $1,348,000 | -22.6% | 17,204 | -0.2% | 0.10% | -26.0% |
| Q2 2016 | $1,741,000 | 0.0% | 17,230 | -6.1% | 0.13% | 0.0% |
| Q1 2016 | $1,741,000 | -7.6% | 18,347 | -9.6% | 0.13% | -6.4% |
| Q4 2015 | $1,885,000 | +4.0% | 20,299 | -4.5% | 0.14% | -1.4% |
| Q3 2015 | $1,812,000 | -4.1% | 21,262 | -3.7% | 0.14% | +35.2% |
| Q2 2015 | $1,889,000 | -10.6% | 22,070 | -11.3% | 0.10% | +11.7% |
| Q1 2015 | $2,113,000 | -5.2% | 24,890 | -4.3% | 0.09% | -6.9% |
| Q4 2014 | $2,229,000 | +2.4% | 26,008 | -9.2% | 0.10% | +4.1% |
| Q3 2014 | $2,176,000 | -33.1% | 28,636 | -30.7% | 0.10% | -31.2% |
| Q2 2014 | $3,255,000 | +2.1% | 41,340 | -2.7% | 0.14% | -2.8% |
| Q1 2014 | $3,188,000 | -3.9% | 42,496 | -1.1% | 0.14% | 0.0% |
| Q4 2013 | $3,317,000 | +8.4% | 42,966 | -2.6% | 0.14% | -0.7% |
| Q3 2013 | $3,059,000 | +4.1% | 44,130 | -4.9% | 0.15% | -2.0% |
| Q2 2013 | $2,939,000 | – | 46,423 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |